Sanofi ‘Strongly Disagrees’ With EMA Rejection Of NAS Status For Nexviadyme

Doctors and medical researchers on conference meeting, discussing possible solutions for resolving a world health crisis.
Sanofi says the CHMP's rejection of NAS status fails to recognize and reward innovation • Source: Alamy

More from Europe

More from Geography